DrBob, 🧠 MechanicMillions are Taking a Drug that Falls Short of its Promise to Lower Risk of #HeartAttack
“While #Fibrates such as #Gemfibrozil (#Lopid) and #Fenofibrate are proven to lower triglyceride levels, which can serve as a biomarker for #Cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of #fenofibrates over and above statins in further reducing #heart-related events.”
#FDA
https://medcitynews.com/2024/09/millions-are-taking-a-drug-that-falls-short-of-its-promise-to-lower-risk-of-heart-attack/
Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack
While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events.